Communicating genetic risk information for common disorders in the era of genomic medicine.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annual review of genomics and human genetics (Print)

• Publication date

  2013-09-04

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1146/annurev-genom-092010-110722PMID 24003856PMCID PMC3862080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Genome Sequencing

  2013cited by this paper
• Communicating Risks and Benefits: An Evidence Based User's Guide

  2012influential reference
• Why do single event probabilities confuse patients?

  2012cited by this paper
• Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing

  2012cited by this paper
• Exploring concordance and discordance for return of incidental findings from clinical sequencing

  2012cited by this paper
• An informatics approach to analyzing the incidentalome

  2012cited by this paper
• Impact of Genetic Notification on Smoking Cessation: Systematic Review and Pooled-Analysis

  2012cited by this paper
• Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease

  2012cited by this paper
• Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.

  2011cited by this paper
• Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes

  2011cited by this paper
• Effect of direct-to-consumer genomewide profiling to assess disease risk.

  2011cited by this paper
• Using plausible group sizes to communicate information about medical risks.

  2011cited by this paper
• Visualizing Uncertainty About the Future

  2011influential reference
• Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling?

  2011cited by this paper
• Charting a course for genomic medicine from base pairs to bedside

  2011cited by this paper
• Genetic risk prediction in complex disease

  2011cited by this paper
• Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk

  2011cited by this paper
• Doctors and Patients’ Susceptibility to Framing Bias: A Randomized Trial

  2011cited by this paper
• Genetic risk estimation in the Coriell Personalized Medicine Collaborative

  2011cited by this paper
• Motivations and Perceptions of Early Adopters of Personalized Genomics: Perspectives from Research Participants

  2011cited by this paper
• Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis

  2011cited by this paper
• Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.

  2010cited by this paper
• Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.

  2010cited by this paper
• Coriell Personalized Medicine Collaborative®: a prospective study of the utility of personalized medicine.

  2010cited by this paper
• Public Awareness of Genetic Influence on Chronic Disease Risk: Are Genetic and Lifestyle Causal Beliefs Compatible?

  2010cited by this paper
• Genetic testing for Alzheimer's and long-term care insurance.

  2010cited by this paper
• Direct‐to‐consumer genetic testing: good, bad or benign?

  2010cited by this paper
• P1‐072: Using APOE to predict “imminent” risk of Alzheimer's disease conversion among patients with MCI: The REVEAL Study

  2010cited by this paper
• Assessment of clinical practices among cancer genetic counselors

  2010cited by this paper
• O2‐01‐05: The psychological impact of learning about APOE‐cardiovascular disease associations during genetic risk assessment for Alzheimer's disease: Findings from the reveal study

  2010cited by this paper
• Personalized genomic information: preparing for the future of genetic medicine

  2010cited by this paper
• How to Reduce the Effect of Framing on Messages About Health

  2010cited by this paper
• Participation in Genetic Testing Research Varies by Social Group

  2010cited by this paper
• Consumers' views of direct-to-consumer genetic information.

  2010cited by this paper
• Lost in translation: Helping patients understand the risks of inflammatory bowel disease therapy†

  2010cited by this paper
• Women’s Experience of Telehealth Cancer Genetic Counseling

  2010cited by this paper
• ‘Your Heart Forecast’: a new approach for describing and communicating cardiovascular risk?

  2010cited by this paper
• Understandings of Basic Genetics in the United States: Results from a National Survey of Black and White Men and Women

  2010cited by this paper
• “I know what you told me, but this is what I think:” Perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate

  2010cited by this paper
• Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers

  2010cited by this paper
• Disclosing the Disclosure: Factors Associated With Communicating the Results of Genetic Susceptibility Testing for Alzheimer's Disease

  2009cited by this paper
• Probability of Precipitation: Assessment and Enhancement of End-User Understanding

  2009cited by this paper
• Finding the missing heritability of complex diseases

  2009influential reference
• Disclosure of APOE genotype for risk of Alzheimer's disease.

  2009cited by this paper
• The ethics and regulation of direct-to-consumer genetic testing

  2009cited by this paper
• Clinical genetics provider real-time workflow study

  2008cited by this paper
• Primary care for children and adolescents with Down syndrome.

  2008cited by this paper
• The Impact Of Web-Based Diabetes Risk Calculators On Information Processing and Risk Perceptions

  2008cited by this paper
• Putting science over supposition in the arena of personalized genomics

  2008cited by this paper
• Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience

  2008cited by this paper
• FRAX™ and the assessment of fracture probability in men and women from the UK

  2008cited by this paper
• Genome-based prediction of common diseases: advances and prospects.

  2008cited by this paper
• Clinical genetics provider real-time workflow study

  2008cited by this paper
• Health Behavior Changes After Genetic Risk Assessment for Alzheimer Disease: The REVEAL Study

  2008cited by this paper
• Delivery of genomic medicine for common chronic adult diseases: a systematic review.

  2008cited by this paper
• Improving understanding of adjuvant therapy options by using simpler risk graphics

  2008cited by this paper
• Genetic exceptionalism. Too much of a good thing?

  2008cited by this paper
• The impact of the format of graphical presentation on health-related knowledge and treatment choices.

  2008cited by this paper
• An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons.

  2008cited by this paper
• Colorectal cancer survivors undergoing genetic testing for hereditary non‐polyposis colorectal cancer: motivational factors and psychosocial functioning

  2007cited by this paper
• Science & society: Educating health-care professionals about genetics and genomics

  2007cited by this paper
• Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

  2007cited by this paper
• Risk Perception, Worry and Satisfaction Related to Genetic Counseling for Hereditary Cancer

  2007cited by this paper
• Genetic information: Special or not? Responses from focus groups with members of a health maintenance organization

  2007cited by this paper
• Numeracy skill and the communication, comprehension, and use of risk-benefit information.

  2007cited by this paper
• Bmc Medical Informatics and Decision Making Risk Communication Formats for Low Probability Events: an Exploratory Study of Patient Preferences

  2007cited by this paper
• Patients’ interpretations of probability terms

  2007cited by this paper
• ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States

  2007cited by this paper
• Risky Communication: Pitfalls in Counseling About Risk, and How to Avoid Them

  2007cited by this paper
• Defining Moments in Risk Communication Research: 1996–2005

  2006cited by this paper
• Recall of disclosed Apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: The REVEAL Study

  2006cited by this paper
• Uptake Rates for Breast Cancer Genetic Testing: A Systematic Review

  2006cited by this paper
• Formats for Improving Risk Communication in Medical Tradeoff Decisions

  2006cited by this paper
• Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis

  2005cited by this paper
• Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)

  2005cited by this paper
• Telegenetics in Maine: Successful clinical and educational service delivery model developed from a 3-year pilot project

  2005cited by this paper
• "A change of heart: how the people of framingham, massachusetts, helped unravel the mysteries of cardiovascular disease".

  2005cited by this paper
• Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior.

  2005cited by this paper
• Reducing the Influence of Anecdotal Reasoning on People’s Health Care Decisions: Is a Picture Worth a Thousand Statistics?

  2005cited by this paper
• Genetic susceptibility testing versus family history–based risk assessment: Impact on perceived risk of Alzheimer disease

  2005cited by this paper
• A change of heart: how the people of Framingham, Massachusetts, helped unravel the mysteries of cardiovascular disease

  2005cited by this paper
• Genetic Risk Assessment for Adult Children of People With Alzheimer’s Disease: The Risk Evaluation and Education for Alzheimer’s Disease (REVEAL) Study

  2005cited by this paper
• Tailored Computer-Based Cancer Risk Communication: Correcting Colorectal Cancer Risk Perception

  2004cited by this paper
• Estimating risk curves for first-degree relatives of patients with Alzheimer’s disease: The REVEAL study

  2004cited by this paper
• Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial

  2004cited by this paper
• Colon Cancer: Risk Perceptions and Risk Communication

  2004cited by this paper
• Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non‐polyposis colon cancer families offered genetic testing

  2003cited by this paper
• Effecting behavior change: awareness of family history.

  2003cited by this paper
• Early adoption of BRCA1/2 testing: Who and why

  2003cited by this paper
• Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services

  2003cited by this paper
• Reasons for Seeking Genetic Susceptibility Testing Among First‐Degree Relatives of People With Alzheimer Disease

  2003cited by this paper
• Genetic testing: psychological aspects and implications.

  2002cited by this paper
• Psychosocial genetic counseling

  2002cited by this paper
• What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review.

  2002cited by this paper
• Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

  2001cited by this paper
• A pilot study of telegenetics

  2000cited by this paper
• Knowledge About Genetic Risk for Breast Cancer and Perceptions of Genetic Testing in a Sociodemographically Diverse Sample

  2000cited by this paper
• Treatment services for children with ADHD: a national perspective.

  2000cited by this paper
• Communicating genetic risk information.

  1999cited by this paper
• Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?

  1999cited by this paper

• Patient Awareness and Acceptance of Pharmacogenomics Services: A Survey of Attitudes Toward PGx Implementation and Pharmacist-Led Care

  2025cites this paper
• Healthcare professionals’ experiences returning monogenic, polygenic, and integrated risk results in the eMERGE study

  2025cites this paper
• Exploring Dutch Citizens’ Perspectives, Expectations, and Decision-Making Regarding Health-Related Direct-to-Consumer Genetic Testing

  2025cites this paper
• Viewing direct-to-consumer genetic test results for depression risk is psychologically well tolerated: Evidence from a longitudinal equivalence study

  2025cites this paper
• The development and evaluation of Polygenic Risk Score reports: A systematised review of the literature.

  2025cites this paper
• Unresolved ethical issues of genetic counseling and testing in clinical psychiatry

  2025cites this paper
• Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives

  2024cites this paper
• Regulating “forever chemicals”: social data are necessary for the successful implementation of the essential use concept

  2024cites this paper
• Impact of polygeNic risk score for glaucoma on psycHosocial ouTcomes (INSiGHT) study protocol

  2024cites this paper
• Effect of communicating genetic risk of type 2 diabetes and wearable technologies on wearable device-measured behavioural outcomes in East Asians: protocol of a randomised controlled trial

  2024cites this paper
• Evaluating an approach for communicating integrated risk scores for melanoma

  2024cites this paper
• Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices

  2024cites this paper
• Development and evaluation of patient-centred polygenic risk score reports for glaucoma screening

  2024influential citation
• Communicating risk and the landscape of cancer prevention — an exploratory study that examines perceptions of cancer-related genetic counseling and testing among African Americans and Latinos in the Midwest

  2023influential citation
• Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests

  2023cites this paper
• De la salud colectiva a la medicina “personalizada”: desafíos bioéticos de la evaluación genética preimplantatoria desde la perspectiva norte-sur

  2023cites this paper
• Knowledge, attitudes and demand toward cardiovascular polygenic risk testing in clinical practice: cross-sectional survey of patients

  2023cites this paper
• Genetics of Alzheimer’s Disease in the African American Population

  2023cites this paper
• Patient satisfaction with return of pharmacogenomic results utilizing a patient portal message.

  2023cites this paper
• Public perspective on medications to delay Alzheimer's disease symptoms

  2023cites this paper
• Information integration through benefit-risk messages on food with quality-adjusted life years from the public agency in Japan: a randomized control study

  2023cites this paper
• Clinical genetic counseling and translation considerations for polygenic scores in personalized risk assessments: A Practice Resource from the National Society of Genetic Counselors

  2023cites this paper
• A Virtual Counselor for Breast Cancer Genetic Counseling: Adaptive Pedagogy Leads to Greater Knowledge Gain

  2022cites this paper
• Addressing the challenges of polygenic scores in human genetic research.

  2022cites this paper
• Tools for communicating risk for Parkinson’s disease

  2022cites this paper
• Models of communication for polygenic scores and associated psychosocial and behavioral effects on recipients: A systematic review.

  2022cites this paper
• Co-design, implementation, and evaluation of plain language genomic test reports

  2022cites this paper
• Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)

  2022cites this paper
• A qualitative study of unaffected ATM and CHEK2 carriers: How participants make meaning of ‘moderate risk’ genetic results in a population breast cancer screening trial

  2022cites this paper
• What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer’s Disease Biomarker Research? A Qualitative Vignette Analysis

  2022cites this paper
• Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication

  2022cites this paper
• Ethical implications of epigenetics in the era of personalized medicine

  2022cites this paper
• Systemic lupus erythematosus as a genetic disease.

  2022cites this paper
• Automating Cancer Genetic Counseling with an Adaptive Pedagogical Agent

  2021cites this paper
• A Systematic Review and Meta-analysis of Complex Interventions to Increase Communication of Diagnosis of Genetic Condition to their Family Members and at-Risk Relatives

  2021influential citation
• The role of emotional sensitivity to probability in the decision to choose genetic testing

  2021cites this paper
• The ethical protection of genetic information: procedure analysis for psychologists

  2021cites this paper
• Investigating the presentation of uncertainty in an icon array: A randomized trial

  2021cites this paper
• Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts

  2021cites this paper
• Genome-wide association studies

  2021cites this paper
• Polygenic risk scores in the clinic: Translating risk into action

  2021cites this paper
• Comparing the impact of an icon array versus a bar graph on preference and understanding of risk information: Results from an online, randomized study

  2021cites this paper
• Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?

  2021cites this paper
• Cascade screening for beta-thalassemia in Pakistan: development, feasibility and acceptability of a decision support intervention for relatives

  2021cites this paper
• Challenges and Opportunities of Targeted Behavioral Interventions for Groups at Risk for Developing Rheumatoid Arthritis

  2021cites this paper
• Acceptability of risk‐stratified population screening across cancer types: Qualitative interviews with the Australian public

  2021cites this paper
• Recommendations for designing genetic test reports to be understood by patients and non-specialists

  2020cites this paper
• Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model.

  2020cites this paper
• Testing a best practices risk result format to communicate genetic risks.

  2020cites this paper
• Risk Assessment and Communication

  2020cites this paper
• Aligning intuition and theory: enhancing the replicability of behaviour change interventions in cancer genetics

  2020cites this paper
• Mixed Hypertrophic and Dilated Phenotype of Cardiomyopathy in a Patient With Homozygous In-Frame Deletion in the MyBPC3 Gene Treated as Myocarditis for a Long Time

  2020cites this paper
• From Probands to Relatives

  2020cites this paper
• Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.

  2020cites this paper
• Uncertainty and certain death: the role of clinical trials in terminal cancer care.

  2020cites this paper
• Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test

  2020cites this paper
• Precision Medicine in Lifestyle Medicine: The Way of the Future?

  2020cites this paper
• The New Genomics Era: Integration of genomics into mainstream oncology and implications for psycho‐oncological care

  2020cites this paper
• Genetiese bevindings in ‘n groep Afrikaners met skisofrenie

  2019cites this paper
• Internet Versus Virtual Reality Settings for Genomics Information Provision

  2019cites this paper
• Exploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative study

  2019cites this paper
• Genome‐wide association studies and polygenic risk scores for skin cancer: clinically useful yet?

  2019cites this paper
• Sickle cell carriers' unmet information needs: Beyond knowing trait status

  2019cites this paper
• Understanding BRCA Mutation Carriers’ Preferences for Communication of Genetic Modifiers of Breast Cancer Risk

  2019cites this paper
• Presenting time-based risks of stroke and death for Patients facing carotid stenosis treatment options: Patients prefer pie charts over icon arrays.

  2019cites this paper
• Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis.

  2019cites this paper
• A Virtual Counselor for Genetic Risk Communication

  2019cites this paper
• Informed Consent and Community Engagement in Genomic Research

  2019cites this paper
• Genomic Knowledge in the Context of Diagnostic Exome Sequencing: Changes over Time, Persistent Subgroup Differences, and Associations with Psychological Sequencing Outcomes

  2019cites this paper
• Nature beyond control: how expectations should inform decisions about human germline engineering

  2019cites this paper
• Personalized Medicine Implementation with Non-traditional Data Sources: A Conceptual Framework and Survey of the Literature

  2019cites this paper
• Epigenetic Risk Assessment of Female Cancers: Women’s Information Needs and Attitudes

  2019cites this paper
• Creating genetic reports that are understood by nonspecialists: a case study

  2019cites this paper
• Vatbaarheid vir skisofrenie by 22q11.2-mikroweglatings

  2019cites this paper
• Agtergrond as rigtingaanwyser

  2019cites this paper
• Vroeë afwykende niepsigotiese gedrag in skisofrenie

  2019cites this paper
• Spesifieke chromosoomgebiede en/of kandidaatgene geïdentifiseer by skisofrenie

  2019cites this paper
• Nader aan die siekbed

  2019cites this paper
• Kliniese kenmerke van Afrikaner-skisofreniepasiënte

  2019cites this paper
• Genomic knowledge in the contextstic exome sequencing : changes over time , persistent subgroup differences , and associations with psychological sequencing outcomes

  2019cites this paper
• Improving Cancer Diagnosis and Care: Clinical Application of Computational Methods in Precision Oncology: Proceedings of a Workshop

  2019cites this paper
• Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials

  2018cites this paper
• Potential use of clinical polygenic risk scores in psychiatry – ethical implications and 1 communicating high polygenic risk 2 3

  2018cites this paper
• Genetic risk information

  2018cites this paper
• A New Era, New Strategies: Education and Communication Strategies to Manage Greater Access to Genomic Information.

  2018cites this paper
• Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial

  2018cites this paper
• Genomic Literacy and Awareness of Ethical Guidance for Genomic Research in Sub-Saharan Africa: How Prepared Are Biomedical Researchers?

  2018cites this paper
• Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals

  2018cites this paper
• Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma

  2018cites this paper
• Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: A randomized controlled trial

  2018cites this paper
• Healthcare professionals’ perceptions of risk in the context of genetic testing for the prediction of chronic disease: a qualitative metasynthesis

  2018cites this paper
• A Visual Approach to Improving the Experience of Health Information for Vulnerable Individuals

  2018cites this paper
• Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk

  2018cites this paper
• Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing

  2018cites this paper
• GenIO: a phenotype-genotype analysis web server for clinical genomics of rare diseases

  2018cites this paper
• Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population

  2018cites this paper
• Genetic counseling in an indigenous Filipino community with a high prevalence of A2ML1-related otitis media

  2018cites this paper
• Ethical issues in neurogenetics.

  2018cites this paper
• Effectiveness of a Web‐Based Personalized Rheumatoid Arthritis Risk Tool With or Without a Health Educator for Knowledge of Rheumatoid Arthritis Risk Factors

  2018cites this paper
• Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers

  2018cites this paper